JP2015518873A5 - - Google Patents

Download PDF

Info

Publication number
JP2015518873A5
JP2015518873A5 JP2015515528A JP2015515528A JP2015518873A5 JP 2015518873 A5 JP2015518873 A5 JP 2015518873A5 JP 2015515528 A JP2015515528 A JP 2015515528A JP 2015515528 A JP2015515528 A JP 2015515528A JP 2015518873 A5 JP2015518873 A5 JP 2015518873A5
Authority
JP
Japan
Prior art keywords
composition
composition according
weight
hours
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2015515528A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015518873A (ja
Filing date
Publication date
Priority claimed from EP12290189.5A external-priority patent/EP2705835A1/en
Application filed filed Critical
Publication of JP2015518873A publication Critical patent/JP2015518873A/ja
Publication of JP2015518873A5 publication Critical patent/JP2015518873A5/ja
Abandoned legal-status Critical Current

Links

JP2015515528A 2012-06-08 2013-06-06 調節された放出をもたらす可溶性の且つ活性の医薬的成分の水性ゲル化組成物 Abandoned JP2015518873A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12290189.5 2012-06-08
EP12290189.5A EP2705835A1 (en) 2012-06-08 2012-06-08 Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release
PCT/EP2013/061732 WO2013182653A1 (en) 2012-06-08 2013-06-06 Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release

Publications (2)

Publication Number Publication Date
JP2015518873A JP2015518873A (ja) 2015-07-06
JP2015518873A5 true JP2015518873A5 (cg-RX-API-DMAC7.html) 2016-07-14

Family

ID=48577065

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015515528A Abandoned JP2015518873A (ja) 2012-06-08 2013-06-06 調節された放出をもたらす可溶性の且つ活性の医薬的成分の水性ゲル化組成物

Country Status (7)

Country Link
US (2) US20150157719A1 (cg-RX-API-DMAC7.html)
EP (2) EP2705835A1 (cg-RX-API-DMAC7.html)
JP (1) JP2015518873A (cg-RX-API-DMAC7.html)
CN (1) CN104487049A (cg-RX-API-DMAC7.html)
HK (1) HK1208171A1 (cg-RX-API-DMAC7.html)
RU (1) RU2014153760A (cg-RX-API-DMAC7.html)
WO (1) WO2013182653A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3539551T (pt) 2011-12-29 2021-11-04 Rhythm Pharmaceuticals Inc Método de tratamento de distúrbios associados ao recetor de melanocortina-4 em portadores heterozigóticos
RU2020120797A (ru) 2013-03-15 2020-07-02 Ритм Фармасьютикалз, Инк. Пептидные композиции
CA3209602A1 (en) 2013-03-15 2014-09-18 Rhythm Pharmaceuticals, Inc. Pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI331922B (en) * 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
CN105837661B (zh) 2005-07-08 2024-10-15 益普生制药股份有限公司 黑皮质素受体配体
AR063120A1 (es) * 2006-10-05 2008-12-30 Panacea Biotec Ltd Composiciones inyectables de deposito y proceso para prepararlas
EP2148692B1 (en) 2007-05-25 2017-01-25 Ipsen Pharma S.A.S. Melanocortin receptor ligands modified with hydantoin
TW200916113A (en) * 2007-08-08 2009-04-16 Sod Conseils Rech Applic Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
WO2009151714A2 (en) * 2008-03-24 2009-12-17 Palatin Technologies, Inc. Therapeutic for treatment of circulatory shock, ischemia, inflammatory disease and related conditions
ES2654147T3 (es) * 2009-11-16 2018-02-12 Ipsen Pharma S.A.S. Composiciones farmacéuticas de ligandos del receptor de melanocortina
EP2720684B1 (en) * 2011-06-14 2019-01-16 Ipsen Pharma S.A.S. A sustained-release composition containing peptides as the active ingredient

Similar Documents

Publication Publication Date Title
JP2014240439A5 (cg-RX-API-DMAC7.html)
HK1247822A1 (zh) 用於活性剂口服给药的制剂
JP2013523677A5 (cg-RX-API-DMAC7.html)
JP2018021007A5 (cg-RX-API-DMAC7.html)
JP2015078230A5 (cg-RX-API-DMAC7.html)
JP2015527402A5 (cg-RX-API-DMAC7.html)
JP2016515561A5 (cg-RX-API-DMAC7.html)
JP2015007131A5 (cg-RX-API-DMAC7.html)
JP2013525493A5 (cg-RX-API-DMAC7.html)
JP2016510019A5 (cg-RX-API-DMAC7.html)
MX365657B (es) Composición novedosa y método de uso para controlar patógenos y prevenir enfermedades en semillas.
JP2015511241A5 (cg-RX-API-DMAC7.html)
AR083422A1 (es) Composiciones y metodos para tratar la hipertension pulmonar
CO6680640A2 (es) Uso de aglutinantes para fabircar formulaciones estables al almacenamiento
JP2016534153A5 (cg-RX-API-DMAC7.html)
JP2011527299A5 (cg-RX-API-DMAC7.html)
JP2016503058A5 (cg-RX-API-DMAC7.html)
JP2016512210A5 (cg-RX-API-DMAC7.html)
MX2013006187A (es) Composiciones farmaceuticas.
JP2017105862A5 (cg-RX-API-DMAC7.html)
JP2017532316A5 (cg-RX-API-DMAC7.html)
CO6170417A2 (es) Formulaciones orales liofilizadas de desintegracion rapida de un antagonista del receptor de trombina
WO2012020301A3 (en) Oral controlled release pharmaceutical compositions of blonanserin
JP2015518873A5 (cg-RX-API-DMAC7.html)
JP2015517484A5 (cg-RX-API-DMAC7.html)